Correlation Between Enlivex Therapeutics and VALTECH SE
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and VALTECH SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and VALTECH SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and VALTECH SE, you can compare the effects of market volatilities on Enlivex Therapeutics and VALTECH SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of VALTECH SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and VALTECH SE.
Diversification Opportunities for Enlivex Therapeutics and VALTECH SE
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Enlivex and VALTECH is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and VALTECH SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VALTECH SE and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with VALTECH SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VALTECH SE has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and VALTECH SE go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and VALTECH SE
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the VALTECH SE. In addition to that, Enlivex Therapeutics is 29.56 times more volatile than VALTECH SE. It trades about -0.05 of its total potential returns per unit of risk. VALTECH SE is currently generating about 0.05 per unit of volatility. If you would invest 9,905 in VALTECH SE on September 1, 2024 and sell it today you would earn a total of 215.00 from holding VALTECH SE or generate 2.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.47% |
| Values | Daily Returns |
Enlivex Therapeutics vs. VALTECH SE
Performance |
| Timeline |
| Enlivex Therapeutics |
| VALTECH SE |
Enlivex Therapeutics and VALTECH SE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and VALTECH SE
The main advantage of trading using opposite Enlivex Therapeutics and VALTECH SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, VALTECH SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VALTECH SE will offset losses from the drop in VALTECH SE's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| VALTECH SE vs. NFT Limited | VALTECH SE vs. Enlivex Therapeutics | VALTECH SE vs. Wisekey International Holding | VALTECH SE vs. Sphere 3D Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world |